Medimetriks Pharmaceuticals Launches Company's First Prescription Brands

Medimetriks introduces 3 new therapies for the Dermatology and Podiatry
Markets

FAIRFIELD, N.J., Jan. 12 /PRNewswire/ -- Medimetriks Pharmaceuticals, Inc.
announced today that the Company launched its first prescription topical
therapies into the Dermatology and Podiatry markets. The three new brands are
Pacnex(TM) (7% Benzoyl Peroxide) Wash, a topical treatment for acne;
Sumaxin(TM) (Sodium Sulfacetamide 10% & Sulfur 4%) Cleansing Pads, a topical
treatment for acne, rosacea and seborrheic dermatitis; and Uramaxin(TM) (45%
Urea) Nail Gel, a treatment for diseased and damaged nails.

A unique attribute of these therapies is the addition of natural ingredients.
The vehicles for Pacnex(TM) Wash and Sumaxin(TM) Cleansing Pads both contain
Green Tea and Aloe, natural ingredients gaining wide acceptance. Green Tea is
known for its antioxidant properties and Aloe for its natural soothing
benefits. Sumaxin(TM) Cleansing Pads also have the unique attribute of a
reduced sulfur odor, addressing a common complaint with sulfur-based topical
therapies. Uramaxin(TM) Nail Gel offers a vehicle containing Menthol, Camphor
and Eucalyptus Oil, ingredients designed to naturally mask the odor often
associated with diseased nails.

"Since the launch of our company eight months ago, Medimetriks' staff has
leveraged its expertise to create and bring to market high quality topical
therapies that offer elegant formulations, provide value to patients, and
enhance patient care," stated Bradley Glassman, President and CEO of
Medimetriks. "These brands were developed with the objective of meeting the
therapeutic needs of both physicians and their patients, and we believe we
have developed three brands that meet that objective."

Medimetriks' new field force is strategically located in the most significant
markets in which the new brands compete. "Physicians are now seeing
Medimetriks Sales Representatives in their offices," said Mr. Glassman.
"These sales professionals are highly trained and charged with the mission of
championing patient care through the ethical promotion of skincare therapy,
delivering knowledge, service and value to our core physician audiences and
their patients."

With the launch of these brands into the Dermatology and Podiatry markets,
Medimetriks will begin to establish a leadership role in supporting the
Dermatology and Podiatry communities. The Company will actively support the
organizations critical to these specialties and provide education important to
their patients.

Medimetriks is planning for the launch of additional topical prescription
therapies in the first quarter of 2009.

Important Product Safety Information:
Pacnex(TM) Wash is for external use only. Avoid contact with eyes, lips or
mucous membranes. If severe irritation develops, discontinue use of Pacnex(TM)
Wash. While using Pacnex(TM) Wash, patients should be advised to avoid
unnecessary sun exposure. Please see full Prescribing Information available
at www.medimetriks.com.

Sumaxin(TM) Cleansing Pads are contraindicated in persons with known or
suspected hypersensitivity to sulfonamides or sulfur. Sumaxin(TM) Cleansing
Pads are not to be used by patients with kidney disease. Although rare,
topical sodium sulfacetamide may cause local irritation. Please see full
Prescribing Information available at www.medimetriks.com.

Uramaxin(TM) Nail Gel is for external use only. Avoid contact with eyes, lips
or mucous membranes. Transient stinging, burning, itching or irritation may
occur and normally disappear on discontinuing the medication. Use as directed.
Please see full Prescribing Information available at www.medimetriks.com.

About Medimetriks Pharmaceuticals, Inc.
Medimetriks Pharmaceuticals, Inc. develops, licenses and commercializes
prescription skincare products primarily for the Dermatology and Podiatry
marketplaces. The Company's mission is to enhance patient quality-of-life by
providing innovative therapies that advance patient care.

The Company is located at 363 Route 46 West, Fairfield, NJ 07004-2402. Please
visit the Medimetriks website at www.medimetriks.com, call (973) 882-7512 or
fax (973) 882-7502.

SOURCE Medimetriks Pharmaceuticals, Inc.

David Addis, Senior Vice President, Brand Communication of Medimetriks
Pharmaceuticals, Inc., +1-973-882-7512, ext. 569